
Description
Clinical-stage biotechnology company developing a new generation of immunotherapies for chronic inflammation
See the website
Case studies
Since March 2024, ALA has worked with Exeliom to support their efforts through the creation and management of press releases, as well as regular content development for LinkedIn.
Read more